Sheena K. Aurora, MD

Vice President, Medical Affairs – Migraine, Impel Neuropharma

Articles

Clinical Takeaways From INP104 Data in Migraine: Sheena K. Aurora, MD

June 26, 2021

The vice president of Medical Affairs in Migraine at Impel discussed the clinical takeaways from the STOP 301 trial of intranasal DHE and the advantages that the novel formulation might offer patients with migraine.